Targeting lymphatic vessel functions through tyrosine kinases.
about
Digitoxin and its analogs as novel cancer therapeuticsIsolation of human lymphatic malformation endothelial cells, their in vitro characterization and in vivo survival in a mouse xenograft model.Platelet-derived growth factors induced lymphangiogenesis: evidence, unanswered questions and upcoming challenges.Differential expression of VEGF ligands and receptors in prostate cancer.
P2860
Targeting lymphatic vessel functions through tyrosine kinases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting lymphatic vessel functions through tyrosine kinases.
@ast
Targeting lymphatic vessel functions through tyrosine kinases.
@en
Targeting lymphatic vessel functions through tyrosine kinases.
@nl
type
label
Targeting lymphatic vessel functions through tyrosine kinases.
@ast
Targeting lymphatic vessel functions through tyrosine kinases.
@en
Targeting lymphatic vessel functions through tyrosine kinases.
@nl
prefLabel
Targeting lymphatic vessel functions through tyrosine kinases.
@ast
Targeting lymphatic vessel functions through tyrosine kinases.
@en
Targeting lymphatic vessel functions through tyrosine kinases.
@nl
P2093
P2860
P356
P1476
Targeting lymphatic vessel functions through tyrosine kinases.
@en
P2093
Marc G Achen
Steven A Stacker
Steven P Williams
Tara Karnezis
P2860
P2888
P356
10.1186/2040-2384-2-13
P577
2010-08-11T00:00:00Z
P5875
P6179
1023766164